Hakan Cakmak, M.D., Mitchell P. Rosen, M.D.
Volume 99, Issue 6, Pages 1476-1484, May 2013
The patients referred for fertility preservation due to a malignant disease do not represent the typical population of subfertile patients treated in the in vitro fertilization units. Cancer may affect multiple tissues throughout the body and can result in variety of complications during controlled ovarian stimulation. Determination of the controlled ovarian stimulation protocol and gonadotropin dose for oocyte/embryo cryopreservation requires an individualized assessment. In this review, we highlight the new protocols that are emerging to reduce time constraints and emphasize management considerations to decrease complications.
Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00445-7/fulltext